Literature DB >> 8692294

Tolerance to nitrates and simultaneous upregulation of platelet activity prevented by enhancing antioxidant state.

E Bassenge1, B Fink.   

Abstract

We analysed the induction of tolerance to nitrates both in the vasculature (in vivo) and platelets (ex vivo). Simultaneously, we tested mechanisms underlying the induction of tolerance and interventions to prevent or overcome this phenomenon. For this purpose nitroglycerin (GTN 1.5 micrograms/kg per min i.v.), alone or in combination with ascorbate (55 micrograms/kg per min i.v.) as antioxidant, was infused continuously for a period of 5 days into chronically instrumented dogs. Along with haemodynamic parameters, ex vivo platelet function was continuously monitored. Following the start of GTN infusions there was a maximal coronary dilator response (245 +/- 15 microm) and, as an index of venodilation, a fall of left ventricular end-diastolic pressure (by 2.3 +/- 0.4 mmHg). Both responses declined progressively and disappeared during the infusion period. However, in combination with ascorbate as antioxidant the dilator responses were maintained fully throughout the infusion period. With GTN alone there was a progressive, unexpected upregulation of platelet activity demonstrated by enhanced thrombin-stimulated intracellular Ca2+ levels and increases in the microviscosity of platelet membranes (indicating enhanced receptor expression) associated with a progressive impairment in basal, unstimulated cGMP levels. These changes could also be prevented completely by i.v. co-administration of ascorbate. From these results it is concluded that vascular tolerance is closely reflected by simultaneous changes in platelet function and further, that both can be prevented completely by appropriate antioxidants such as ascorbate.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8692294     DOI: 10.1007/bf00168641

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  25 in total

1.  Counter-regulatory responses to continuous and intermittent therapy with nitroglycerin.

Authors:  J D Parker; B Farrell; T Fenton; M Cohanim; J O Parker
Journal:  Circulation       Date:  1991-12       Impact factor: 29.690

2.  Protein kinase C and cyclic AMP regulate reversible exposure of binding sites for fibrinogen on the glycoprotein IIB-IIIA complex of human platelets.

Authors:  G van Willigen; J W Akkerman
Journal:  Biochem J       Date:  1991-01-01       Impact factor: 3.857

3.  Solving the mystery of nitrate tolerance. A new scent on the trail?

Authors:  H L Fung
Journal:  Circulation       Date:  1993-07       Impact factor: 29.690

Review 4.  Nitrate therapy in patients with coronary artery disease--preparations and doses with and without development of tolerance.

Authors:  W Rudolph; J Dirschinger; F Kraus; G Reiniger; D Hall
Journal:  Z Kardiol       Date:  1990

5.  Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide.

Authors:  J S Beckman; T W Beckman; J Chen; P A Marshall; B A Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

6.  Long-term angiotensin-converting enzyme inhibition with high-dose enalapril retards nitrate tolerance in large epicardial arteries and prevents rebound coronary vasoconstriction in vivo.

Authors:  T Münzel; E Bassenge
Journal:  Circulation       Date:  1996-06-01       Impact factor: 29.690

Review 7.  Nitrates in different vascular beds, nitrate tolerance, and interactions with endothelial function.

Authors:  E Bassenge; J Zanzinger
Journal:  Am J Cardiol       Date:  1992-09-24       Impact factor: 2.778

8.  Platelet cyclic GMP. A potentially useful indicator to evaluate the effects of nitroglycerin and nitrate tolerance.

Authors:  H Watanabe; M Kakihana; S Ohtsuka; T Enomoto; K Yasui; Y Sugishita
Journal:  Circulation       Date:  1993-07       Impact factor: 29.690

9.  Long-term nitroglycerin treatment: effect on direct and endothelium-mediated large coronary artery dilation in conscious dogs.

Authors:  D J Stewart; J Holtz; E Bassenge
Journal:  Circulation       Date:  1987-04       Impact factor: 29.690

10.  Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance.

Authors:  T Münzel; H Sayegh; B A Freeman; M M Tarpey; D G Harrison
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

View more
  5 in total

1.  The nitric oxide donor SIN-1 is free of tolerance and maintains its cyclic GMP stimulatory potency in nitrate-tolerant LLC-PK1 cells.

Authors:  B Hinz; H Schröder
Journal:  Pharm Res       Date:  1999-05       Impact factor: 4.200

Review 2.  The enigma of nitroglycerin bioactivation and nitrate tolerance: news, views and troubles.

Authors:  B Mayer; M Beretta
Journal:  Br J Pharmacol       Date:  2008-06-23       Impact factor: 8.739

3.  Dietary supplement with vitamin C prevents nitrate tolerance.

Authors:  E Bassenge; N Fink; M Skatchkov; B Fink
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

Review 4.  Organic nitrates and nitrate resistance in diabetes: the role of vascular dysfunction and oxidative stress with emphasis on antioxidant properties of pentaerithrityl tetranitrate.

Authors:  Matthias Oelze; Swenja Schuhmacher; Andreas Daiber
Journal:  Exp Diabetes Res       Date:  2010-12-27

5.  Metabolomics-Driven Elucidation of Cellular Nitrate Tolerance Reveals Ascorbic Acid Prevents Nitroglycerin-Induced Inactivation of Xanthine Oxidase.

Authors:  Elizabeth Rose Axton; Eleonso Cristobal; Jaewoo Choi; Cristobal L Miranda; Jan Frederik Stevens
Journal:  Front Pharmacol       Date:  2018-09-25       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.